ANSELL LIMITED (ANN)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ANN - ANSELL LIMITED

Year End: June
GICS Industry Group : Health Care Equipment & Services
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Ansell is an Australian manufacturer of protective industrial equipment and household and medical gloves. It is the remnant of Pacific Dunlop, once a mighty conglomerate that listed in 1985. The name was changed to Ansell in 2002.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$26.97

18 May
2022

0.230

OPEN

$26.98

0.86%

HIGH

$27.42

450,017

LOW

$26.81

TARGET
$30.518 13.2% upside
Franking for last dividend paid out: 0%
OTHER COMPANIES IN THE SAME SECTOR
ASB . LGD . SRV . KPG . AIM . CUP . QHL . DGL .
FNARENA'S MARKET CONSENSUS FORECASTS
ANN: 1
Title FY22
Forecast
FY23
Forecast
EPS (cps) 175.5 xxx
DPS (cps) 74.3 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 15.3 xxx
Dividend Yield 2.8% xxx
Div Pay Ratio(%) 42.3% xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

N/A

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 09/03 - ex-div 34.07c (franking 0%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 201620172018201920202021
EPS Basic xxxxxxxxxxxxxxx257.6
DPS All xxxxxxxxxxxxxxx160.8
Sales/Revenue xxxxxxxxxxxxxxx2,717.2 M
Book Value Per Share xxxxxxxxxxxxxxx1,622.4
Net Operating Cash Flow xxxxxxxxxxxxxxx207.0 M
Net Profit Margin xxxxxxxxxxxxxxx12.17 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201620172018201920202021
Return on Capital Employed xxxxxxxxxxxxxxx16.18 %
Return on Invested Capital xxxxxxxxxxxxxxx12.06 %
Return on Assets xxxxxxxxxxxxxxx9.18 %
Return on Equity xxxxxxxxxxxxxxx16.18 %
Return on Total Capital xxxxxxxxxxxxxxx16.22 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-7.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Credit Suisse

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

16/02/2022

2

Accumulate

$33.00

22.36%

Ansell's December first-half result broadly met Ord Minnett's estimates but the dividend sharply disappointed.

Ord Minnett notes the company is hostage to the rapid covid-induced decline for gloves and the company destocking, hitting margins.

Elsewhere, business lines were solid and sales guidance sans gloves was strong.

The broker expects margins and earnings will recover over the next 18 months as destocking slows; expects a sharp improvement in cash flow in the second half as working-capital pressure subsides, and tinkers with earnings estimates.

Accumulate rating retained, the broker expecting demand for hygiene and PPE products will continue and that higher costs can be fully passed on to consumers in an inflationary environment. Target price steady at $33.

This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.

FORECAST
Ord Minnett forecasts a full year FY22 dividend of 69.59 cents and EPS of 173.28 cents.
Ord Minnett forecasts a full year FY23 dividend of 79.14 cents and EPS of 195.12 cents.

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

ANN STOCK CHART